Table 4 Risk of YAHL associated with... | American Society of Hematology

Table 4

Risk of YAHL associated with IL-12 1188 3′UTR polymorphism among case-twins and controls with DNA samples available

IL-12 +1188 A>C	Case-twins	Controls	OR (95% CI)*	OR† (95% CI)	P‡
All case-twins vs controls
AA	24	28	1.0	1.0	—
AC/CC	21/2	11/0	2.44 (0.99-6.01)	2.81 (1.08-7.30)	.03
MZ§ case-twins vs controls
AA	18	28	1.0	1.0	—
AC/CC	18/2	11/0	2.83 (1.10-7.27)	3.04 (1.14-8.14)	.03

IL-12 +1188 A>C	Case-twins	Controls	OR (95% CI)*	OR† (95% CI)	P‡
All case-twins vs controls
AA	24	28	1.0	1.0	—
AC/CC	21/2	11/0	2.44 (0.99-6.01)	2.81 (1.08-7.30)	.03
MZ§ case-twins vs controls
AA	18	28	1.0	1.0	—
AC/CC	18/2	11/0	2.83 (1.10-7.27)	3.04 (1.14-8.14)	.03

— indicates not applicable.

Crude odds ratio (OR) and 95% confidence intervals (95% CI).

ORs adjusted for age (categoric: ≤30, 31-40, 41-50, and 51-60 years) and sex.

P values for the adjusted OR.

Monozygotic.